PRNP and prion disease: Notably, the similar opposite effect of PrPT183A on the PrPSc amplification in the two Tg mouse–derived substrates between fCJDT183A and all other prion diseases examined above including sCJD, VPSPr, and fCJDV180I was also observed in human brain–derived PrPC substrates (Fig. 2).